Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.61 |
| ▸ | PARP1 | P09874 | 8/20 | 0.53 |
| ▸ | AR | P10275 | 6/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | ENPP1 | P22413 | 2/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19748913 | 1.00 | CYP3A4 (0.61) | CYP3A4CYP2C9TSHRCYP2C19PARP1 | |
| SCHEMBL19748738 | 0.85 | CYP3A4 (0.80) | CYP3A4CYP2C9TSHRCYP2C19PARP1 | |
| SCHEMBL29654995 | 0.85 | CYP3A4 (0.80) | CYP3A4CYP2C9TSHRCYP2C19PARP1 | |
| SCHEMBL19747907 | 0.84 | CYP3A4 (0.61) | CYP3A4CYP2C9TSHRCYP2C19PARP1 | |
| SCHEMBL29655241 | 0.84 | CYP3A4 (0.61) | CYP3A4CYP2C9TSHRCYP2C19PARP1 | |
| SCHEMBL19748662 | 0.83 | CYP3A4 (0.65) | CYP3A4CYP2C9TSHRCYP2C19PARP1 | |
| SCHEMBL29655199 | 0.83 | CYP3A4 (0.65) | CYP3A4CYP2C9TSHRCYP2C19PARP1 | |
| SCHEMBL29655104 | 0.82 | ENPP1 (0.62) | CYP3A4CYP2C9TSHRCYP2C19PARP1 | |
| SCHEMBL19748357 | 0.82 | ENPP1 (0.62) | CYP3A4CYP2C9TSHRCYP2C19PARP1 | |
| SCHEMBL4572876 | 0.81 | PARP1 (0.72) | CYP3A4CYP2C9TSHRCYP2C19PARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109843874-B | Phthalazine derivatives useful as inhibitors of PARP1, PARP2 and/or tubulin for the treatment of cancer | 加利福尼亚大学董事会 | 2022-05-27 | — | — | CN | disclosed |